# Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

> **NCT00455624** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Androgen deprivation therapy

## Key facts

- **NCT ID:** NCT00455624
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455624, "Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00455624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*